Wellington Partners

Wellington Partners is a Munich-based venture capital firm with offices in London and Zurich that invests in technology and life sciences companies across Europe. It targets early-stage and growth-stage opportunities in Digital Media, Software, Electronics and Photonics, Resource Efficiency and Biotech/Life Sciences, including digital health, industrial biotechnology and IT/TMT sectors. The firm provides entrepreneurs with resources to execute their strategies and typically leads rounds, with investments ranging from approximately €0.5 million to €20 million and potential commitments up to €15 million depending on maturity. Since its founding in 1998, it has backed European startups through multiple investment vehicles focused on technology and life sciences.

Frank Boehnke

General Partner

Frank Böhnke

General Partner

Rolf Dienst

General Partner

Johannes Fischer

principal

Ulrich Granzer

Venture Partner

Varun Gupta Ph.D

Principal

Dr. Regina Hodits

Managing Partner

Harald Keller

CFO and Managing Partner

Karl Naegler

Managing Partner

Karl Nagler

Managing Partner

Eberhard Plattfaut Ph.D

Venture Partner

Christian Reitberger Ph.D

General Partner

Dr. Rainer Strohmenger

Managing Partner

Kai Wohlberedt

Associate

Past deals in Germany

Aignostics

Series B in 2024
Founded in 2018, Aignostics develops AI-powered diagnostics and pathology software solutions for pharmaceutical research and clinical applications. Its explainable AI overcomes the limitations of conventional 'black-box' AI by providing precise heatmaps and image overlays, enabling pathologists to verify results quickly.

4TEEN4 Pharmaceuticals

Series C in 2024
4TEEN4 Pharmaceuticals develops precision medicines for acute cardiovascular conditions, focusing on restoring cardiac and vascular function in critical care by creating humanized antibodies and related biomarkers and diagnostic tools. Its lead program, Procizumab, is a humanized antibody targeting DPP3 for the treatment of acute cardiovascular diseases. It also develops DPP3 as a diagnostic biomarker for indications such as acute heart failure, myocardial infarction, cardiogenic shock, and septic shock, along with accompanying diagnostic tools. The company evolved from Sphingotec Therapeutics and is based in Hennigsdorf, Germany.

Onward

Post in 2024
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Orcan Energy

Private Equity Round in 2022
Founded in 2008 as a spin-out from the Technical University of Munich, Orcan Energy specializes in waste heat recovery technology. The company develops, manufactures, and sells energy solutions based on Organic Rankine Cycle (ORC) technology, converting waste heat into electricity for industrial, marine, automotive, power generation, and biogas markets.

Aignostics

Series A in 2022
Founded in 2018, Aignostics develops AI-powered diagnostics and pathology software solutions for pharmaceutical research and clinical applications. Its explainable AI overcomes the limitations of conventional 'black-box' AI by providing precise heatmaps and image overlays, enabling pathologists to verify results quickly.

iOmx Therapeutics

Series B in 2021
iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The company focuses on creating first-in-class cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. Utilizing a proprietary siRNA-based screening technology, iOmx systematically analyzes human tumor cells to identify innovative therapeutic targets and understand their mechanisms of action. The company's approach is rooted in the principles of cancer immune-checkpoint therapy, which aims to overcome tumors' inherent resistance to immune attacks. This resistance is often mediated by cell surface molecules that inhibit T cell activation. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Onward

Venture Round in 2021
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Adrenomed

Series E in 2020
Adrenomed is a privately financed, clinical-stage biopharmaceutical company focused on restoring vascular integrity in critically ill patients. Its lead candidate, Adrecizumab, is a humanized monoclonal antibody that targets Adrenomedullin, a regulator of the vascular system, to reduce vascular leakage and stabilize circulation in conditions such as sepsis and septic shock and acute heart failure. The company employs a biomarker-guided approach, pairing the antibody with Adrenomedullin measurements to identify suitable patients. Headquartered in Hennigsdorf, near Berlin, Germany, Adrenomed develops therapeutic and diagnostic strategies to treat acute circulatory failure and improve survival in high-risk conditions.

AMBOSS

Series B in 2019
AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

Adrenomed

Series D in 2018
Adrenomed is a privately financed, clinical-stage biopharmaceutical company focused on restoring vascular integrity in critically ill patients. Its lead candidate, Adrecizumab, is a humanized monoclonal antibody that targets Adrenomedullin, a regulator of the vascular system, to reduce vascular leakage and stabilize circulation in conditions such as sepsis and septic shock and acute heart failure. The company employs a biomarker-guided approach, pairing the antibody with Adrenomedullin measurements to identify suitable patients. Headquartered in Hennigsdorf, near Berlin, Germany, Adrenomed develops therapeutic and diagnostic strategies to treat acute circulatory failure and improve survival in high-risk conditions.

4TEEN4 Pharmaceuticals

Venture Round in 2018
4TEEN4 Pharmaceuticals develops precision medicines for acute cardiovascular conditions, focusing on restoring cardiac and vascular function in critical care by creating humanized antibodies and related biomarkers and diagnostic tools. Its lead program, Procizumab, is a humanized antibody targeting DPP3 for the treatment of acute cardiovascular diseases. It also develops DPP3 as a diagnostic biomarker for indications such as acute heart failure, myocardial infarction, cardiogenic shock, and septic shock, along with accompanying diagnostic tools. The company evolved from Sphingotec Therapeutics and is based in Hennigsdorf, Germany.

Heliatek

Series D in 2017
Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

Heliatek

Series D in 2016
Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

iOmx Therapeutics

Series A in 2016
iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The company focuses on creating first-in-class cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. Utilizing a proprietary siRNA-based screening technology, iOmx systematically analyzes human tumor cells to identify innovative therapeutic targets and understand their mechanisms of action. The company's approach is rooted in the principles of cancer immune-checkpoint therapy, which aims to overcome tumors' inherent resistance to immune attacks. This resistance is often mediated by cell surface molecules that inhibit T cell activation. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Rigontec

Series A in 2016
Rigontec GmbH is a biopharmaceutical company based in Planegg, Germany, focused on developing RNA-based immunotherapeutics for cancer and viral diseases. Founded in 2014, the company is recognized for its innovative approach to immuno-oncology, particularly through its lead compound ImOl100. This compound acts as a stimulator of the immune receptor retinoic acid-inducible gene I (RIG-I), which detects viral RNA and promotes immune responses. ImOl100 serves as a minimal mimic of naturally occurring 3pRNA, a motif commonly found in viral RNAs, and aims to overcome the limitations associated with traditional cancer vaccines and checkpoint inhibitors. As of October 2017, Rigontec operates as a subsidiary of Merck & Co., enhancing its capabilities in the development of effective therapeutic options for patients.

Onward

Series A in 2016
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

AMBOSS

Seed Round in 2015
AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

4SC

Post in 2015
4SC is a clinical-stage biopharmaceutical company focused on discovering and developing targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases, particularly in areas with significant unmet medical needs. The company aims to offer innovative treatment options that enhance tolerability and efficacy, ultimately improving patients' quality of life. 4SC's drug development pipeline includes two clinical candidates, resminostat and Domatinostat, which are protected by a strong portfolio of patents. The company operates primarily in Germany and the European Union, while also generating revenue from various other countries.

Rigontec

Series A in 2015
Rigontec GmbH is a biopharmaceutical company based in Planegg, Germany, focused on developing RNA-based immunotherapeutics for cancer and viral diseases. Founded in 2014, the company is recognized for its innovative approach to immuno-oncology, particularly through its lead compound ImOl100. This compound acts as a stimulator of the immune receptor retinoic acid-inducible gene I (RIG-I), which detects viral RNA and promotes immune responses. ImOl100 serves as a minimal mimic of naturally occurring 3pRNA, a motif commonly found in viral RNAs, and aims to overcome the limitations associated with traditional cancer vaccines and checkpoint inhibitors. As of October 2017, Rigontec operates as a subsidiary of Merck & Co., enhancing its capabilities in the development of effective therapeutic options for patients.

ImevaX

Series A in 2014
ImevaX GmbH is a biopharmaceutical company based in Munich, Germany, founded in 2014. The company specializes in developing vaccines targeting pathogens that cause chronic infectious diseases and nosocomial infections. ImevaX's approach involves creating specific vaccines against immune evasion factors used by these pathogens to control infections. Their lead candidate is IMX 101, a vaccine designed to combat Helicobacter pylori, a bacterium that colonizes the stomach and is linked to ulcer disease and gastric cancer in humans. The company’s research focuses on understanding and neutralizing bacterial factors that down-regulate the host immune system, a mechanism used by many highly infectious pathogens. Additionally, ImevaX offers diagnostic tests for early detection of Helicobacter pylori infections.

Rigontec

Series A in 2014
Rigontec GmbH is a biopharmaceutical company based in Planegg, Germany, focused on developing RNA-based immunotherapeutics for cancer and viral diseases. Founded in 2014, the company is recognized for its innovative approach to immuno-oncology, particularly through its lead compound ImOl100. This compound acts as a stimulator of the immune receptor retinoic acid-inducible gene I (RIG-I), which detects viral RNA and promotes immune responses. ImOl100 serves as a minimal mimic of naturally occurring 3pRNA, a motif commonly found in viral RNAs, and aims to overcome the limitations associated with traditional cancer vaccines and checkpoint inhibitors. As of October 2017, Rigontec operates as a subsidiary of Merck & Co., enhancing its capabilities in the development of effective therapeutic options for patients.

Heliatek

Series C in 2014
Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

AYOXXA

Series B in 2014
AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Definiens

Venture Round in 2014
Definiens is a provider of image analysis and data mining solutions specifically designed for quantitative digital pathology within the life sciences, diagnostic biomarkers, and healthcare sectors. The company's software delivers detailed insights from whole tissue slides, cell-based assays, and full body scans, enabling the integration of this information with data from various sources. By automating analysis workflows, Definiens enhances the capabilities of pharmaceutical and biotechnology companies, research institutions, clinical service organizations, and pathologists, facilitating informed decision-making in research, diagnostics, and therapy. Headquartered in Munich, Germany, with additional offices in the United States, Definiens aims to advance research, contribute to the development of personalized medicine, and improve patient outcomes.

Orcan Energy

Series B in 2013
Founded in 2008 as a spin-out from the Technical University of Munich, Orcan Energy specializes in waste heat recovery technology. The company develops, manufactures, and sells energy solutions based on Organic Rankine Cycle (ORC) technology, converting waste heat into electricity for industrial, marine, automotive, power generation, and biogas markets.

SuperSonic Imagine

Private Equity Round in 2013
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Hailo Network

Venture Round in 2013
Hailo Network, established in 1947, is a global manufacturer and supplier of ladder systems, steps, and waste bins, renowned for its innovative products and safety standards. The company, headquartered in Germany, operates in over 60 countries worldwide, distributing its products through a network of retailers and distributors.

Hailo Network

Series B in 2012
Hailo Network, established in 1947, is a global manufacturer and supplier of ladder systems, steps, and waste bins, renowned for its innovative products and safety standards. The company, headquartered in Germany, operates in over 60 countries worldwide, distributing its products through a network of retailers and distributors.

AYOXXA

Series A in 2012
AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Readmill

Series A in 2012
Readmill is a Berlin-based social reading platform that enables users to engage with ebooks in a collaborative manner. Founded by CEO Henrik Berggren, the platform allows individuals to highlight passages from their readings, share these highlights with friends, and initiate discussions about the content. Readmill has established partnerships with several independent bookstores, enhancing its offerings through collaborations with platforms such as Leanpub, Readlists, Free-ebooks.net, Jottify, OR Books, Publit, and Bibliocrunch. By fostering a community-oriented approach to reading, Readmill aims to enrich the reading experience and promote meaningful interactions around literature.

Hailo Network

Series A in 2012
Hailo Network, established in 1947, is a global manufacturer and supplier of ladder systems, steps, and waste bins, renowned for its innovative products and safety standards. The company, headquartered in Germany, operates in over 60 countries worldwide, distributing its products through a network of retailers and distributors.

bonusbox

Seed Round in 2012
Bonusbox GmbH, established in 2011 and headquartered in Berlin, Germany, specializes in operating an online customer retention platform for merchants. This platform facilitates multi-partner loyalty networks, enabling merchants to attract new customers and retain existing ones through incentive schemes. By integrating seamlessly into merchants' websites, bonusbox allows customers to earn points with each purchase, which can be redeemed instantly for rewards or tracked alongside other purchases. The platform also provides merchants with valuable insights into customer behavior by structuring previously disparate data.

Sapiens Steering Brain Stimulation

Series A in 2011
Sapiens Steering Brain Stimulation GmbH is a medical device company focused on advancing deep brain stimulation (DBS) therapy. Founded in 2011 as a spin-out of Royal Philips Electronics, Sapiens operates from offices in Eindhoven, the Netherlands, and Munich, Germany. The company is dedicated to developing a high-resolution, MRI-compatible DBS system designed to enhance patient comfort and improve therapeutic outcomes, particularly for individuals with Parkinson's disease. Sapiens’ innovative approach includes a unique steering brain stimulation system and image-guided programming, both of which are based on patented technologies.

Enecsys

Series B in 2011
Enecsys Limited is a company specializing in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems. These products are designed to convert direct current (DC) from solar modules into clean alternating current (AC) for integration into the electricity grid. Enecsys micro inverters are known for their ability to maximize energy harvest, enhance safety, and provide improved reliability and performance monitoring. The company's monitoring system allows for real-time tracking of each photovoltaic module's performance through a robust wireless communication network that connects to the Internet. Headquartered in Cambridge, UK, Enecsys also maintains sales and support offices in Germany, the USA, and Taiwan, serving both residential and commercial markets.

Orcan Energy

Series A in 2011
Founded in 2008 as a spin-out from the Technical University of Munich, Orcan Energy specializes in waste heat recovery technology. The company develops, manufactures, and sells energy solutions based on Organic Rankine Cycle (ORC) technology, converting waste heat into electricity for industrial, marine, automotive, power generation, and biogas markets.

Hailo Network

Seed Round in 2011
Hailo Network, established in 1947, is a global manufacturer and supplier of ladder systems, steps, and waste bins, renowned for its innovative products and safety standards. The company, headquartered in Germany, operates in over 60 countries worldwide, distributing its products through a network of retailers and distributors.

Experteer

Series C in 2011
Experteer is a Munich-based online career and recruitment marketplace that specializes in high-end job opportunities across Europe. Founded in 2005, the platform features over 80,000 job listings targeted at experienced executives and senior professionals. Experteer provides access to a discreet network of more than 8,000 recruiters and 10,000 headhunters, facilitating connections to the hidden job market. The platform offers premium services that include personalized job recommendations, market insights, and salary benchmarks, all curated by a dedicated team of recruitment professionals. Additionally, Experteer serves as a resource for headhunters, providing job advertising and candidate sourcing solutions. Overall, Experteer aims to support candidates in managing their careers effectively while also connecting companies with top-tier talent.

AZZURRO Semiconductors

Venture Round in 2010
AZZURRO Semiconductors AG is a semiconductor company based in Magdeburg, Germany, founded in 2003. The company specializes in manufacturing and marketing gallium nitride on silicon (GaN-on-Si) epitaxial wafers, which are essential for various applications including high voltage electronics, field-effect transistors (FETs), light-emitting diodes (LEDs), automotive components, and switching devices for power supplies. AZZURRO Semiconductors AG's products facilitate advancements in semiconductor development and are utilized in a range of technologies, including sensors. As of April 30, 2014, the company is undergoing liquidation.

MTM Laboratories

Series C in 2010
MTM Laboratories develops and manufactures In-Vitro Diagnostics for early detection and diagnosis of cervical and other cancers. Headquartered in Heidelberg, Germany, with subsidiaries in the US, France, Italy, and Spain, MTM markets its proprietary CINtec® Histology Kit and CINtec® Cytology Kit as adjunct tools for cervical cancer diagnosis.

Experteer

Series B in 2010
Experteer is a Munich-based online career and recruitment marketplace that specializes in high-end job opportunities across Europe. Founded in 2005, the platform features over 80,000 job listings targeted at experienced executives and senior professionals. Experteer provides access to a discreet network of more than 8,000 recruiters and 10,000 headhunters, facilitating connections to the hidden job market. The platform offers premium services that include personalized job recommendations, market insights, and salary benchmarks, all curated by a dedicated team of recruitment professionals. Additionally, Experteer serves as a resource for headhunters, providing job advertising and candidate sourcing solutions. Overall, Experteer aims to support candidates in managing their careers effectively while also connecting companies with top-tier talent.

eCircle

Private Equity Round in 2010
eCircle is a provider of software and services for digital dialog marketing in Europe, specializing in email marketing solutions. Founded in 1999 and headquartered in Munich, Germany, the company operates additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy. eCircle offers a range of products, including software for email and SMS broadcasting, as well as email address data for newsletter mailings and various marketing campaigns. In addition to its software offerings, eCircle provides consulting services to help clients optimize their marketing strategies, along with social media functionalities to enhance engagement.

EnOcean

Venture Round in 2009
EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

Heliatek

Series B in 2009
Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

Enecsys

Series A in 2009
Enecsys Limited is a company specializing in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems. These products are designed to convert direct current (DC) from solar modules into clean alternating current (AC) for integration into the electricity grid. Enecsys micro inverters are known for their ability to maximize energy harvest, enhance safety, and provide improved reliability and performance monitoring. The company's monitoring system allows for real-time tracking of each photovoltaic module's performance through a robust wireless communication network that connects to the Internet. Headquartered in Cambridge, UK, Enecsys also maintains sales and support offices in Germany, the USA, and Taiwan, serving both residential and commercial markets.

EnOcean

Series D in 2008
EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

GameDuell

Venture Round in 2008
GameDuell is a Berlin-based developer and provider of casual and social online games, boasting over 125 million registered players across various platforms. Established in 2003 by Kai Bolik, Michael Kalkowski, and Boris Wasmuth, the company offers a diverse portfolio of more than 70 games, primarily developed in-house. Their range includes digital card and board games, action arcade titles, and puzzle games, commonly played across the web, social networks, and mobile devices. Notable titles in their lineup include Fluffy, Maya Pyramid, Bubble Speed, Jungle Jewels, and classic games such as Hearts, Solitaire, and Pool. With a team of 210 experienced professionals, GameDuell is recognized as a significant player in the casual gaming sector within Western markets.

Experteer

Series A in 2007
Experteer is a Munich-based online career and recruitment marketplace that specializes in high-end job opportunities across Europe. Founded in 2005, the platform features over 80,000 job listings targeted at experienced executives and senior professionals. Experteer provides access to a discreet network of more than 8,000 recruiters and 10,000 headhunters, facilitating connections to the hidden job market. The platform offers premium services that include personalized job recommendations, market insights, and salary benchmarks, all curated by a dedicated team of recruitment professionals. Additionally, Experteer serves as a resource for headhunters, providing job advertising and candidate sourcing solutions. Overall, Experteer aims to support candidates in managing their careers effectively while also connecting companies with top-tier talent.

Heliatek

Series A in 2007
Heliatek GmbH, founded in 2006 and based in Dresden, Germany, specializes in the development and manufacture of organic photovoltaics (OPV) solutions, particularly HeliaSol and HeliaFilm. These innovative products are designed for integration into various building surfaces, including horizontal, vertical, and curved structures, making them suitable for retrofitting existing buildings as well as for new construction. Heliatek's OPV technology is characterized by its ultra-lightweight and flexible nature, contributing to environmentally friendly energy solutions. The company serves a diverse clientele, including those in the building and construction materials industry, automotive manufacturers, and suppliers, and has established strategic partnerships with firms such as AGC Glass Europe and Reckli China. With approximately 160 employees, Heliatek is at the forefront of advancing organic electronics, utilizing advanced roll-to-roll manufacturing processes in controlled environments to produce its solar films.

Adviqo

Series D in 2007
Adviqo Group, established in 2000 and based in Berlin, Germany, is a leading media organization specializing in live counseling services tailored for female audiences. It operates a diverse portfolio that includes TV channels, online marketplaces, eCommerce sites, websites, and mobile applications, focusing on life advice, therapeutic counseling, and coaching. The company has a significant presence across five countries—Germany, the UK, France, Spain, and Poland—employing over 350 staff members. Adviqo is recognized as an exclusive content partner for prominent women's magazines and major online platforms, enhancing its reach and influence. With a strong management team drawn from various reputable firms and supported by notable investors, Adviqo has consistently achieved high double-digit revenues and maintained profitability.

Ingent

Series A in 2007
Ingent Inc., a Germany-based provider of information retrieval infrastructure technologies for computer applications.

MTM Laboratories

Series C in 2006
MTM Laboratories develops and manufactures In-Vitro Diagnostics for early detection and diagnosis of cervical and other cancers. Headquartered in Heidelberg, Germany, with subsidiaries in the US, France, Italy, and Spain, MTM markets its proprietary CINtec® Histology Kit and CINtec® Cytology Kit as adjunct tools for cervical cancer diagnosis.

VoiceObjects

Series C in 2006
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Negevtech

Series D in 2006
Negevtech, Ltd. provides patterned wafer optical inspection systems for the semiconductor industry. It offers Negevtech 3100, a wafer inspection system that offers wafer inspection of memory devices in front-end and back-end of line inspection applications. The company offers products for finding defects and controlling yields in semiconductor wafer processing. It has facilities in Texas, Idaho, Japan, Korea, Taiwan, China, Singapore, and Germany. The company was founded in 1999 and is based in Santa Clara, California with an additional office in Rehovot, Israel.

XING

Series A in 2005
XING Is the social network for business professionals. More than 13 million members worldwide – over 6.5 million of whom are based in german-speaking countries – use xing to boost their business, job, and career. Xing is a platform where professionals from all kinds of different industries can meet up, find jobs, colleagues, new assignments, cooperation partners, experts and generate business ideas. Members can meet and exchange views in over 50,000 specialist groups, while also getting together at networking events. The platform is operated by xing ag, which was founded in hamburg, germany, in 2003, has been publicly listed since 2006, and listed on the tecdax since september 2011. In december 2010, xing acquired amiando ag, a munich-based company and europe’s leading provider of online event management and ticketing. The acquisition of kununu gmbh, the leading platform for employer reviews in german-speaking countries, allows xing to extend its position as the social recruiting market leader.

VoiceObjects

Venture Round in 2005
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Collax

Series A in 2005
Collax GmbH, founded in 2005 and based in Ismaning, Germany, specializes in developing Linux-based server solutions tailored for small to medium-sized enterprises. The company offers a range of products, including the Collax Business Server for network management, the Collax OX Server for information exchange, and the Collax Security Gateway for unified threat management. Collax’s solutions encompass various aspects of IT infrastructure, including network security, data management, email, collaboration, and web services, all designed to enhance productivity while ensuring robust security. With additional offices in Munich and Boston, Collax aims to provide adaptable and stable IT environments that support the growth of its clients' businesses.

EnOcean

Series C in 2005
EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

SAFE ID Solutions

Series A in 2005
SAFE ID Solutions AG provides integrated security solutions to the ID market for security and convenience in the issuance and personalization process. It offers secure eID systems and infrastructures with professional solutions for various markets, such as security, passport, ID card, visa, and border security infrastructures. The company provides document issuance solutions, including biometric enrolment, personalization management software, and optical and electronic personalization of ID documents, as well as offers document verification and border control solutions. Its customers include the governments of Kazakhstan, Spain, Turkey, Liechtenstein, Egypt, the Dominican Republic, and Costa Rica. The company has a strategic partnership with Singapore Technologies Electronics Ltd. SAFE ID Solutions AG was founded in 2003 and is headquartered in Munich, Germany. It operates showrooms in Munich, Germany; and Singapore, Singapore.

VoiceObjects

Series B in 2004
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

EnOcean

Series B in 2004
EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

MTM Laboratories

Series B in 2003
MTM Laboratories develops and manufactures In-Vitro Diagnostics for early detection and diagnosis of cervical and other cancers. Headquartered in Heidelberg, Germany, with subsidiaries in the US, France, Italy, and Spain, MTM markets its proprietary CINtec® Histology Kit and CINtec® Cytology Kit as adjunct tools for cervical cancer diagnosis.

EnOcean

Series A in 2002
EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

eCircle

Venture Round in 2000
eCircle is a provider of software and services for digital dialog marketing in Europe, specializing in email marketing solutions. Founded in 1999 and headquartered in Munich, Germany, the company operates additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy. eCircle offers a range of products, including software for email and SMS broadcasting, as well as email address data for newsletter mailings and various marketing campaigns. In addition to its software offerings, eCircle provides consulting services to help clients optimize their marketing strategies, along with social media functionalities to enhance engagement.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.